Cargando…
Itaconate and Its Derivatives Repress Early Myogenesis In Vitro and In Vivo
A Krebs cycle intermediate metabolite, itaconate, has gained attention as a potential antimicrobial and autoimmune disease treatment due to its anti-inflammatory effects. While itaconate and its derivatives pose an attractive therapeutic option for the treatment of inflammatory diseases, the effects...
Autores principales: | Oh, Tae Seok, Hutchins, Damian C., Mainali, Rabina, Goslen, Kevin H., Quinn, Matthew A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898833/ https://www.ncbi.nlm.nih.gov/pubmed/35265064 http://dx.doi.org/10.3389/fimmu.2022.748375 |
Ejemplares similares
-
Skeletal myotube-derived extracellular vesicles enhance itaconate production and attenuate inflammatory responses of macrophages
por: Yamaguchi, Atomu, et al.
Publicado: (2023) -
Research Progress on the Mechanism of Itaconate Regulating Macrophage Immunometabolism
por: Shi, Jia, et al.
Publicado: (2022) -
Itaconate family-based host-directed therapeutics for infections
por: Yuk, Jae-Min, et al.
Publicado: (2023) -
Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis
por: Kuo, Ping-Chang, et al.
Publicado: (2020) -
Alleviating glucose repression and enhancing respiratory capacity to increase itaconic acid production
por: Xu, Yaying, et al.
Publicado: (2022)